<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00547781</url>
  </required_header>
  <id_info>
    <org_study_id>VLC-JD-0704-307-12</org_study_id>
    <nct_id>NCT00547781</nct_id>
  </id_info>
  <brief_title>Implantation Failure and PGD</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Instituto Valenciano de Infertilidad, IVI VALENCIA</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Instituto Valenciano de Infertilidad, IVI VALENCIA</source>
  <brief_summary>
    <textblock>
      The aim of this study is to performed a randomized controlled trial to evaluate the
      usefulness of preimplantation genetic diagnosis (PGD) in patients with repetitive
      implantation failure. Patients will be prospectively randomized in two groups: standard IVF
      with blastocyst transfer on day-5 and transfer day-5 after PGD for aneuploidy screening for
      chromosomes 13, 15, 16, 18, 21, 22, X and Y. The end points of the study are: Cancellation
      rate; implantation rate and ongoing implantation rate. Inclusion criteria are: patients with
      ≥2 previous IVF failure without clinical or biochemical pregnancy with transfer of at least 2
      good quality embryos per transfer. Exclusion criteria will be uterine abnormalities ,
      abnormal karyotypes, abnormal result in thrombophilia screening and low responder patients
      (less than 4 expected oocytes).
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>July 2007</start_date>
  <completion_date type="Actual">January 2012</completion_date>
  <primary_completion_date type="Actual">January 2012</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <enrollment type="Anticipated">250</enrollment>
  <condition>IMPLANTATION</condition>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>PGD</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients of any age with ≥2 previous cycles, negative TIG or biochemical pregnancy
             with fresh transfer of at least 2 embryos in each cycle.

        Exclusion Criteria:

          -  Patients with PGD indication (age, repetitive miscarriage, chromosomal anomalies, etc.
             )

          -  Patients with ectopic pregnancies in previous cycles.

          -  Recipient of oocyte donation.

          -  Patients in which 4 or less oocytes are to be retrieved.
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Carmen Rubio, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>IVI Valencia</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>IVI Valencia</name>
      <address>
        <city>Valencia</city>
        <zip>46117</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <verification_date>March 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 22, 2007</study_first_submitted>
  <study_first_submitted_qc>October 22, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 23, 2007</study_first_posted>
  <last_update_submitted>March 30, 2012</last_update_submitted>
  <last_update_submitted_qc>March 30, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 2, 2012</last_update_posted>
  <responsible_party>
    <name_title>Dr. Carmen Rubio</name_title>
    <organization>IVI Valencia</organization>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

